-
April 2008: FDA Web Site Adds Two New Pages For Learning About Drug Safety
Some Important Terms Are Defined And Various Research Resources From FDA Are Listed (Posted by Tom Lamb at DrugInjuryWatch.com) On April 11, 2008 the FDA added to its web site one page that gives…
-
Ortho Evra, Preemption, And The New York Times: Another Drug Company Response Letter
And, We Learn About More Of Merck’s Vioxx Shenanigans — Another Benefit Of Pharmaceutical Product Liability Litigation (Posted by Tom Lamb at DrugInjuryWatch.com) For the second time in as many weeks, it was the…
-
Ortho-McNeil’s Response To April 2008 NYT Article About Ortho Evra And FDA / Federal Preemption
New York Times Reporters Gardiner Harris and Alex Berenson Bring Attention To How This Emerging Legal Issue Would Affect Drug Injury Cases (Posted by Tom Lamb at DrugInjuryWatch.com) To our pleasant surprise, we saw…
-
April 2008 FDA “Patient Safety News” Videos For Doctors Online
Covers Chantix And Ortho Evra, As Well As Botox And Myobloc (Posted by Tom Lamb at DrugInjuryWatch.com) The FDA’s Patient Safety News (PSN) is a series of monthly video news shows intended primarily for…
-
March 2008: Higher Doses Of Celebrex Are Associated With Heart Attack And Stroke Risks
Lower, More Popular Dose Presumed To Be Safe, But Definitive Study Results Will Not Be Available For Few More Years (Posted by Tom Lamb at DrugInjuryWatch.com) On March 31, 2008, at the American College…